About 3DHEALS Company Directory:

3DHEALS updates this collection of public and private companies, government and non-government institutions, and any relevant research organizations in healthcare 3D printing, bioprinting, AR/VR, 3D technologies, on a weekly basis. Access to this directory is free to 3DHEALS Premium and Enterprise members. 

THIS CONTENT IS FOR PREMIUM AND ENTERPRISE MEMBERS ONLY.

Add your company to 3DHEALS Directory:

(Please click the same above buttons for significant updates of your organizational information. Map is updated monthly.)

blank

CELLnTEC

CELLnTEC remains a small and focused company, with continuing activities in the development of advanced new culture products and testing services. 

Headquarters Stauffacherstr 130A Bern 3014 Switzerland
Categories: Stem Cells
Website: cellntec.com
CEO: Peter Girling Co-Founder Phone: +41 (0)31 331 9582 Phone: +41 (0)31 331 9583
Links:

Details

Officially, it all started with a few signatures and the thump of a notary’s stamp.

Inventory on day one: 2 dim rental rooms, 2 second-hand instruments, 2 new products, and 2 eager employees.  Customers at the end of the first quarter: also just 2.

Fast forward 15 years, and CELLnTEC now serves hundreds of customers in over a dozen countries with around 50 products specifically designed for 6 different epithelial tissues.

But if we only consider our story from the official start in 2002, we miss a more intriguing tale that describes how CELLnTEC fits within the 50 year-old history of epithelial cell culture.

> Read about how CELLnTEC is continuing a story started in 1959.

For those who like to skip to the end: the story culminates with a new, 5th generation of epithelial culture products, known as the CnT-Prime media.

Built on 4 previous generations of media extending back to 1959, the CnT-Prime media feature new components included to better mimic micro-environments such as the stem cell niche, and to influence signalling pathways controlling self-renewal, proliferation, and differentiation.

CELLnTEC remains a small and focused company, with continuing activities in the development of advanced new culture products and testing services.  It is rewarding to keep pushing the epithelial cell culture boundaries back – and we have no intention of stopping.

– Peter Girling, Co-Founder

CBD for pain is gaining traction as a complementary option for everyday discomfort, offering potential anti-inflammatory benefits and calmer sensations without strong sedatives. Results vary, so start with a low dose, choose reputable full- or broad-spectrum products, and monitor changes. Always consult a healthcare professional if you have underlying conditions or take other medications. cbdclub.top